Carlisle Companies Incorporated (CSL)

Operating profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Operating income US$ in thousands 1,143,100 982,800 1,275,700 336,600 487,800
Revenue US$ in thousands 5,003,600 4,586,900 6,591,900 4,810,300 3,969,900
Operating profit margin 22.85% 21.43% 19.35% 7.00% 12.29%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $1,143,100K ÷ $5,003,600K
= 22.85%

Based on the provided data, Carlisle Companies Incorporated has exhibited fluctuating operating profit margins over the past five years. The company's operating profit margin stood at 12.29% as of December 31, 2020, but decreased to 7.00% by the end of 2021. However, there was a significant improvement in the operating profit margin in the following years, reaching 19.35% by December 31, 2022, 21.43% by December 31, 2023, and further increasing to 22.85% by December 31, 2024.

The upward trend in operating profit margins from 2021 to 2024 indicates that Carlisle Companies Incorporated has been effectively managing its operating expenses relative to its revenue, resulting in improved profitability. This may be attributed to cost control measures, operational efficiencies, pricing strategies, or changes in the product mix that have positively impacted the company's bottom line.

Overall, the steady increase in operating profit margins reflects positively on Carlisle Companies Incorporated's ability to generate profits from its core business operations and suggests a potential strengthening of the company's financial health and operational performance over the years analyzed.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating profit margin
Carlisle Companies Incorporated
CSL
22.85%
West Pharmaceutical Services Inc
WST
19.70%